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Abstract: 2-Piperidineethanol (1) and its corresponding N-protected aldehyde (2) were used for the
synthesis of several natural and synthetic compounds. The existence of a stereocenter at position 2 of
the piperidine skeleton and the presence of an easily-functionalized group, such as the alcohol, set 1
as a valuable starting material for enantioselective synthesis. Herein, are presented both synthetic
and enzymatic methods for the resolution of the racemic 1, as well as an overview of synthesized
natural products starting from the enantiopure 1.
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1. Introduction
2-Piperidineethanol (1) (Figure 1) is a chiral piperidine derivative bearing two functional group
suitable for diversified elaborations of the molecule.
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Figure 1. Structure of 2-piperidineethanol (1) and the corresponding N-protected aldehyde (2). 
With more than 10,000 molecules listed in SciFinder, contain the substructure of 
2-piperidineethanol keeping the stereocentre in position 2 of piperidine, its potentiality is self-evident 
as a valuable chiral starting material in organic synthesis. In racemic form, it is a quite cheap 
compound since it is synthesized, on an industrial scale, by catalytic hydrogenation of 
2-(2-hydroxyethyl)pyridine [1]; on the contrary, the enantiopure form is expensive and less 
available. 
N-protected aldehyde (2), easily obtained by controlled oxidation of the parent alcohol, is the 
derivative of 2-piperidineethanol usually used to a great extent in synthesis. 
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The racemic compound is clearly related to the main exploitations but in the last decades there
was a growing utilization of the enantiopure form, mostly concerning the synthesis of new leads in
medicinal chemistry and the total synthesis of natural compounds.
Per se, it is utilized in the industrial plants for CO2 capture [2]; as racemic starting compound
was used in the synthesis of the catalysts for Ziegler–Natta polymerization [3]. It is used as scaffold
for the synthesis of insect and mite repellents [4] as Icaridin (trade name Saltidin) [5]; tert-butyl
carbamate (N-Boc) protected 2-piperidineethanol was patented as anthelminthic agents for humans and
animals [6]. In medicinal chemistry, several leads were synthesized from racemic 1; it is worth citing the
synthesis of a new orexin receptor antagonist [7], of a new class of non-opiate antinociceptive agents [8],
of (aryloxyalkyl)piperidines as calcium channel antagonists [9] and of sulfonamide derivatives as 5-HT7
receptor (5-hydroxytryptamine receptor 7) antagonists [10]. In some cases, a further improvement
of activity was granted with the proper enantiomer, for example, the synthesis of aminoindane
compounds as sodium channel inhibitors and TRPV1 receptor (transient receptor potential cation
channel subfamily V member 1) activator for the treatment of pain [11], of a novel non-xanthine
adenosine A1 receptor antagonist [12], of dermal anesthetic agents [13], of gonadotropin-releasing
hormone antagonists [14], of a new inhibitor of cyclin-dependent kinases [15], of non-peptide
quinolone GnRH (gonadotropin-releasing hormone) receptor antagonists [16] and of selective thrombin
inhibitors [17].
Nature is the prime developer of compounds with a piperidine backbone with many
structurally-interesting alkaloids; the wide range of biological activities in this family of natural
products make them ideal targets for total synthesis. A selection of synthesis of alkaloids starting from
enantiopure 1 is displayed at the end of this review.
2. Enantiopure 2-Piperidineethanol: Resolution versus Synthesis
Some research groups took into account the enantioselective synthesis of 1 or aldehyde 2; an
early strategy was established on intermolecular nitrone cycloadditions to chiral allyl ethers [18,19]
obtaining benzyl carbamate (N-Cbz) 2. Asymmetric allylation was the next synthetic tool using
a chiral auxiliary [20,21]; a synthetic sequence involving a Maruoka asymmetric allylation with a
chiral catalyst [22] was successful in obtaining N-Boc 2. Recently, a straightforward organocatalyzed
intramolecular aza-Michael reaction accomplished the synthesis of either N-Boc or N-Cbz 2 in high
enantiomeric excess (e.e.) [23,24]. To obviate to the numerous synthetic steps necessary in the synthesis
of 1 from scratch was also taken advantage of the homologation of the commercially-available
N-(Boc)-S-pipecolic acid by carboxyl reduction, modified Swern oxidation, Wittig olefination, and enol
ether acidic hydrolysis [25].
Resolution of the racemic mixture certainly provides practical benefits, considering the low
price and good availability of 1, although suffers from the disadvantage that only half of the starting
material is transformed into the desired product. Resolution can then offer the most cost efficient
route to the enantiomerically pure chiral synthon. Indeed, it was the first method used to obtain the
enantiopure isomer by careful recrystallization of the diasteroisomeric D-10-camphorsulfonate salt
from ethanol-ether [26]. This method generally provided the alcohol in low yield, since there was a
strong tendency for the racemic salt to separate, rather than the diastereoisomeric forms and numerous
sequential recrystallizations were required to achieve enantiomeric excess of 95%. The procedure was
subjected at slight modifications as it was repeated by several research groups and, although with
some drawbacks, was used for the production of 12 kg of (R)-(´)-2-piperidineethanol [12]. Recently,
the pushing necessity for a better resolving agent, brought about the development of two patents that
utilized either N-sulphonyl pyroglutamic acid [27] or N-acetyl-L-leucine [28]: a single crystallization
of the corresponding diastereoisomeric salt with 1, was enough to achieve high enantiomeric excess
(86% and 95%, respectively) and higher with the second crystallization (99% and 98%, respectively).
Int. J. Mol. Sci. 2016, 17, 17 3 of 15
Enantiopure 2-Piperidineethanol by Enzymatic Kinetic Resolutions
Enzymatic kinetic resolutions of racemates have been widely exploited in the past years for
the preparation of enantiopure compounds [29–31]. Despite the breakthroughs achieved through
the ability of enzymes to selectively react with only one of the enantiomers from a racemic mixture,
there are only few examples reported for the resolution of 1, each one related to the reactivity at the
hydroxyl group. It was a difficult task, due to the fact that the molecule is a conformationally flexible
and primary alcohol located two carbons away from the molecule stereocenter. An early reference
approached the resolution of several racemic piperidine derivatives [32] with either a stereocenter in
position 2 or 3, exploiting the hydrolysis of an ester group by pig liver esterase (EC 3.1.1.1). With 1 two
strategies were tested (Scheme 1) by the synthesis of esters 3 and 4:
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Scheme 1. Synthesis of 2-piperidineethanol derivatives suitable for hydrolysis by pig liver esterase.
iPr: isopropyl.
They were subjected to pig liver esterase hydrolysis at pH 7.0 to avoid the possibility of competing
chemical hydrolysis or epimerization under the higher pH conditions; reactions were stopped after
50% conversion: results are reassumed in Scheme 2 showing a generally low enantioselectivity with
up to 24% e.e. for acid (5).
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enantiomeric excess.
In 1994, a first example of exploitation of the porcine pancreas lipase (PPL) for the resolution of
9-fluorenylmethyl carbamate (N-Fmoc) 2-piperidineethanol (7) was reported in a Japanese patent [33]:
vinyl acetate was used as the acylating agent and diisopropyl ether as solvent (Scheme 3) (in the
English abstract are not indicated the e.e. of both the enantioenriched 8 and 7).
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Finally, in 2003, a comprehensive study on the enantioselective acylation of the residual primary
alcohol (Scheme 4) by lipases was successfully realized [34]. A first screening of over 20 different
lipase preparations was performed at 45 ˝C; an organic solvent (methyl tert-butyl ether) was selected
as solvent as it is well-known that the enzymatic performances (activity and selectivity) can be
enhanced greatly using organic solvents as a reaction medium, rather than their natural aqueous
environments [35]; the protective groups of amino group tested were Boc, Cbz, and Fmoc.
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Scheme 4. Enzymatic enantioselective acylation of racemic 9. Pg: protecting group.
This preliminary screening underlined that reaction enantioselectivities were generally quite low.
The crude porcine pancreatic preparation possessed an opposite enantioselectivity compared to all
the other lipases and Lipase PS was the more selective enzyme among the “(R)-lipases”. Comparing
the three protective groups, N-Boc derivative was a slightly better substrate. A new screening was
directed to pointing out the effect of different solvents for the reaction of N-Boc derivative catalyzed
by Lipase PS and PPL: hexane was a slightly better solvent for the former while methyl tert-butyl ether
remained the solvent of choice for the latter.
Finally, an opti ized protocol as designed based on the observed co ple entary
enantioselectivity of the t o enzymes (Scheme 5). The racemic mixture 9 was acetylated under
the best condition for Lipase PS; after that enzyme is filtered and reagent re oved, the crude ixture
as butanoylated by the PPL under the best condition for this enzyme. In this way, the low selectivity
of the two lipases was enhanced. The final mixture, composed by enantioenriched acetate (R)-10,
butanoate (S)-11 and the unreacted almost racemic 9, was easily purified by flash chromatography.
Hydrolysis of the two esters was follo ed by a second step of acetylation on the two enantioenriched
alcohols by the two lipases; after hydrolysis, both alcohols with high e.e. were obtained.
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Scheme 5. Optimized protocol. (a) AcOCH=CH2, hexane, 20 ˝C, 190 min (45%); (b) PrCOOCH=CH2,
MTBE, 20 ˝C, 11.5 h (30%), flash chromatography (AcOEt-hexane 1:9); (c) CH3OH, Na2CO3; and
(d) AcOCH=CH2, MTBE, 20 ˝C, 46 h (48%). PPL: porcine pancreas lipase; PS: Lipase PS; Pr: propyl;
Ac: acetyl; Boc: tert-butyl carbamate.
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3. An Overview of the Synthetic Strategies in the Synthesis of Alkaloids Starting from Either
Enantiopure 1 or 2
The development of suitable methods for accessing both enantiomers of 1 opened the path to the
total synthesis of a wide range of natural compounds with high interest in medicinal chemistry; in an
early stage, some of these syntheses were performed starting with racemic 1.
As previously mentioned, 2 is the main derivative of 2-piperidineethanol used in total synthesis
where the stereogenic center at the C-2 position would readily encode the remaining stereochemical
information into the final target. It is usually synthesized by Swern oxidation, but some troubles
affect the recovery of the product and the scale up of the reaction. An enzymatic approach at the
oxidation reaction of (R)-9 was realized by exploiting laccases [36], either from Trametes pubescens
or from Myceliophtora termophyla, TEMPO (2,2,6,6-tetramethyl-1-piperidinyloxy) as a mediator, and
molecular oxygen of the air as the primary oxidant (Scheme 6).
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3.1. Enantioselective Synthesis of the Alkaloid (+)-Aloperine
Aloperine (12) (Scheme 7) is a member of a small family of C15 alkaloids that is extracted
from the seeds and leaves of Sophora alopecuroides, a shrub that grows in China and Russia, and
later from Leptorhabdos parviflor Benth. Its pharmac logical activity spreads between cardiovascular,
anti-inflammatory, and a ti-allergic f atures producing an inten e synthe ic interest in this molecule.
In 2002, a synthesis of racemic 12 was realiz d [37]; the synthetic strategy (Scheme 7) relied on an
efficient intermolecular Diels-Alder reaction as crucial step where derivative 15 was a key building
block for the synthesis of the N-acylaminodiene 14.
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In 2004, the corresponding enantioselective variant [36] was performed starting from (R)-9 for the
synthesis of (R)-17 (Scheme 8); two consecutive enzymatic oxidations mediated by laccase were set for
both the synthesis of aldehyde (R)-2 and ketone (R)-17.
Int. J. Mol. Sci. 2016, 17, 17 6 of 15
Int. J. Mol. Sci. 2016, 17, 0017 6 of 15 
 
 
Scheme 8. Synthesis of intermediate (R)-17. TBAF: tetrabutylammonium fluoride. TMS: trimethylsilyl. 
3.2. Enantioselective Synthesis of the Alkaloid Boehmeriasin A 
Boehmeriasin A (22) is a phenanthroquinolizidine alkaloid extracted from Boehmeria siamensis 
Craib. It possesses a strong cytotoxic activity, more potent than taxol, against 12 cell lines from six 
panels of cancer including breast, kidney, prostate, colon, lung cancer, and leukemia, with 
topoisomerases and SIRT2 as involved targets. Recently, the synthesis of enantiopure 22 [38] was 
accomplished starting from aldehyde (S)-2 (Scheme 9). 
 
Scheme 9. Synthesis of the alkaloid boehmeriasin A. (a) (4-methoxyphenyl)magnesium bromide; (b) 
DMP; (c) TMSCl, MeOH; (d) 2-bromo-4,5-dimethoxyphenylacetic acid, DIPEA, 1-(Bis(dimethylamino) 
methylene)-1H-1,2,3-triazolo(4,5-b)pyridinium 3-oxid hexafluorophosphate (HATU); (e) KOH, EtOH; 
(f) Pd(OAc)2, K2CO3, 2′-(diphenylphosphino)-N,N′-dimethyl-(1,1′-biphenyl)-2-amine; and (g) LiAlH4. 
The synthetic sequence begins with the Grignard addition to the enantiopure aldehyde (S)-2 
followed by oxidation with DMP (Dess-Martin periodinane), deprotection of the Boc group, N-acylation 
of the amine, intramolecular aldol-type condensation, and palladium-catalyzed intramolecular 
coupling and reduction of the amide. 
Recently, a quite similar synthetic strategy [39] was used for the synthesis of sulfonamide analogues 
of 22 as potent and orally active antitumor agents. 
  
Scheme 8. Synthesis of intermediate (R)-17. TBAF: tetrabutylammonium fluoride. TMS: trimethylsilyl.
3.2. Enantioselective Synthesis of the lkaloid Boeh eriasin
Boeh eriasin (22) is a phenanthroquinolizidine alkaloid extracted fro Boeh eria sia ensis
Craib. It possesses a strong cytotoxic activity, more potent than taxol, against 12 cell lines from six panels
of cancer including breast, kidney, prostate, colon, lung cancer, and leukemia, with topoisomerases and
SIRT2 as involved targets. Recently, the synthesis of enantiopure 22 [38] was accomplished starting
from aldehyde (S)-2 (Sche e 9).
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Scheme 9. Synthesis of the alkaloid boehmeriasin A. (a) (4-methoxyphenyl)magnesium bromide;
(b) DMP; (c) TMSCl, MeOH; (d) 2-bromo-4,5-dimethoxyphenylacetic acid, DIPEA, 1-(Bis(dimethylamino)
methylene)-1H-1,2,3-triazolo(4,5-b)pyridiniu 3-oxid hexafluorophosphate (HATU); (e) KOH, EtOH;
(f) Pd(OAc)2, K2CO3, 21-(diphenylphosphino)-N,N1-dimethyl-(1,11-biphenyl)-2-amine; and (g) LiAlH4.
The synthetic sequence begins with the Grignard addition to the enantiopure aldehyde (S)-2
followed by oxidatio with DMP (Dess-Martin periodina e), deprotection of the Boc group, N-acylation
of the ami e, intramolecular aldol-type condensation, and palladium-catalyzed intramolecular
coupling and reduction of the amid .
Recently, a quite similar synthetic strategy [39] was used for the synthesis of sulfonamide
analogues of 22 as potent and orally active antitumor agents.
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3.3. Enantioselective Synthesis of the Alkaloid Dumetorine
Dumetorine (28) is an alkaloid with piperidine structural unit that is extracted from
the tubers of Dioscorea dumetorum Pax and used in folk medicine and arrow poisons. The
enantioselective synthesis [40] was established on few key synthetic steps (Scheme 10) starting from
the enantiopure aldehyde (S)-2. The second stereocenter was achieved by an asymmetric allylboration
reaction with β-allyl-diisopinocamphenylborane, obtaining exclusively the required compound 23
(diastereoisomeric excess (de) > 95%). After acylation with acryloyl chloride, the dihydropyran ring
was synthesized by ring-closing metathesis reaction with the second generation Grubbs catalyst.
Unfortunately, the removal of the Boc group with TFA (trifluoroacetic acid) involved the formation of
the byproduct 26, as the main component of the reaction mixture, and the desired free amine 27 in
small amounts (10%). Finally, N-methylation was carried out by reductive amination with CH2O in
the presence of NaBH3CN to give the target natural (+)-28.
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Scheme 10. Enantioselective synthesis of the alkaloid dumetorine. (a) CH2=CHCH3CH2MgBr,
(+)-β-methoxydiisopinocamphenylborane; (b) CH2=CHCOCl; (c) Grubb’s II catalyst; (d) TFA
(trifluoroacetic acid); and (e) CH2O, NaBH3CN.
Recently, for the improvement of the synthesis, a sequence of five separate synthetic steps,
was performed by flow chemistry technology with the advantages of mini al workup and
purification [41]. Packed colum s containing appr riate immobilized reagents r scavenger materials
were used. The starting compound was the e antiopure alcohol (S)-9 that was converted into the
corresponding aldehy e (S)-2 by continuously cycling the flow stream through a polymer-supported
2-iodoxybenzamide pre-packed column. In the second step, the insertion of the allyl group was realized
by reaction with the Grignard reagent 2-methyl-allylmagnesium bromide; the two diastereoisomers,
formed almost in 1:1 ratio, were purified on a silica gel cartridge to give the desired diastereoisomer
23. After acylation with acryloyl chloride, the ring-closing metathesis reaction was realized by a
new PEG (polyethylene glycol)-supported Hoveyda catalyst working in homogeneous conditions
ensured by the solubility of the catalyst in CH2Cl2, maintaining the possibility of simple catalyst
recovery by solvent-promot d precipitation and filtration. Th inherent i stability of amine 27 was the
main drawback of the early synthetic sequence (Scheme 10) since Michael addit on f the secondary
amine to the α,β-unsaturated lactone ring caused the formation of the byproduct 26 nd significantly
reduced the yield of the final reductive amination (39%). A definitive breakthrough was established by
converting directly Boc protected 25 in final product 28 through an Eschweiler–Clarke reaction with
formaldehyde in the presence of formic acid at high temperature: flash heating with a rapid warming
to 140 ˝C gave a clean product with a yield of 92%.
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3.4. Enantioselective Synthesis of the Alkaloids Sedamine, Allosedamine, Sedridines and Ethylnorlobelols
The structure of several alkaloids are easily recognized as derivatives of the reaction of 2 with
an appropriate Grignard reagent. Indeed, starting from the enantiopure (S)-2, two diastereoisomeric
alcohols 29 and 30 were generated (Scheme 11). Their Boc groups were easily converted into methyl
groups by reduction with LiAlH4 [34] affording, for R = Ph, respectively, (´)-sedamine (31) and
(´)-allosedamine (32); alternatively, 31 was synthesized from 29, through flow chemistry technology,
by the protocol developed for the previously outlined Eschweiler–Clarke reaction [41].
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On the other hand, removing the Boc group from 29 and 30 afforded respectively (´)-allosedridine
(33) and (+)-sedridine (34), for R = Me, (´)-21-epi-ethylnorlobelol (35) and (+)-ethylnorlobelol (36), for
R = Et [42].
3.5. Synthesis of the Enantiopure Alkaloids Coniine and Epidihydropinidine
Coniine (38) is the major alkaloid extracted from Conium maculatum (poison hemlock) and
responsible for its toxicity. It was synthesized from the enantiopure (S)-2 (Scheme 12) by elongating the
chain at the 2-position of the piperidine ring through a Wittig reaction, hydrogenation of the double
bound and removal of the Boc group [42].
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Closely related to coniine is the alkaloid epidihydropinidine (43) that shared the same synthetic
steps for the building of the propyl group [40]. The key synthetic step was the Beak’s N-Boc-piperidine
α-lithiation/alkylation methodology for the introduction of the methyl group at the C-6 position;
TBDMS protection of the hydroxyl group of (R)-9 was important in order to keep the C-2 chain at
a distance from the reactive center (Scheme 13). After deprotection and Dess–Martin oxidation to
aldehyde 42, the synthesis proceeded alike Scheme 12.
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Scheme 13. Enantioselective synthesis of the alkaloid (´)-epidihydropinidine. (a) imidazole,
tert-butyldimethylsilyl chloride (TBDMSCl); (b) N,N,N1,N1-Tetramethylethylenediamine (TMEDA),
sec-BuLi, Et2O, ´78 ˝C, MeSO4; (c) Na2CO3, MeOH; and (d) Dess-Martin reagent.
3.6. nantioselective Synthesis of olycyclic iperidine erivatives
he changeover of the al ehy e group of 2 into the carbon–carbon double bond of 37 allowed
a switch of reactivity by exploiting reactions affecting the alkene group [43] such as intra olecular
eck reactions, 1,3-dipolar cycloadditions, ring closing metathesis and intramolecular chloroamination
reactions, reaching an increased molecular complexity. Indeed, bicyclic derivative 45 was obtained by
reaction of urea 44 using Pd(CH3CN)2Cl2 as a catalyst and uCl2 as an oxidant (Scheme 14).
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Scheme 14. Enantioselective synthesis of bicyclic derivative 45.
i i more reactions together in order to m difying the carbon–carbon double bond before
the 1,3-dipolar cycloaddition, all wed the stereoselective synthesis of fused tricyclic derivatives with
up to three ster og nic c ters. Then, aryl derivative 46 was subjected to an intramolecular Heck
reaction (Scheme 15) obtaining the bicyclic alkene 47 that, after 1,3-dipolar cycloaddition, gave th
tricyclic spiro derivati e 48 as mixture of two diastereoisomers.
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Likewise, derivative 49 was subjected to ring-closing metathesis (Scheme 16) by a Grubbs catalyst
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Further examples of natural compounds synthesized starting from both enantiopure 1 or 2 are
shortly exemplified in this subsection; the substructure derived from 1 is pointed ou in red.
4.1. Enantioselective Synthesis of the Alkaloids (´)-Oncinotine, (´)-Isooncinotine, and (´)-Stellettamide B
(´)-Onc n tine (52) and (´)-isooncin ti e (53) (Figure 2) are a gr up of isomeric polyamine
alkaloids which e characteriz d y macrocyclic lactams containing the biogene ic base spermidine;
they are isolated fro the stem bark of Oncinotis nitida (Apocynaceae). 52 was synthesized in 1996 [19]
starting from N-Cbz 2 instead. 53 was synthesized in 2007 [44] from 1. Stellettamide B (54) (Figure 2) is
extracted from a marine sponge of the genus Stelletta and showed antifungal and cytotoxic activity;
it was synthesized in 2001 [20] from 1.
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4.2. Enantioselective Synthesis of the Alkaloids (+)-Vertine and (+)-Lythrine
The azabicyclic skeleton of quinolizidine is a relevant structural subunit present in numerous
alkaloids and can be built starting from 1. (+)-Vertine (55) and (+)-lythrine (56) are examples of this
class of natural compounds (Figure 3); they are extracted from Decodon verticillatus and displayed a
wide range of biological activities, such as anti-inflammatory, sedative, and antispasmodic actions;
recently, was realized their total synthesis starting from 1 [45].
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4.4. Enantioselective Synthesis of the Alkaloids (´)-Cermizine C, (´)-Senepodine G and (+)-Cermizine D
From the family of lycopodi m alkaloids are worth to mention (´)-Cermizine C (60) and
(+)-cermizine D (62), both isolated fro t e club moss Lycopodium cernuum and the related alkaloid
(´)-senepodine G (61) from the club moss Lycopodium chinense (Figure 5); the second latter displaced
modest cytotoxicity against murin lymphoma L1210 cells. 60 was ynthesized from 61 by reduction
with NaBH4, while the synthesis of the latter was accomplished starting from 1 [47,48]. Enantioselective
synthesis of 62 exploited the use of N-Boc 2 as common intermediate to access two of the three
piperidine rings [49].
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4.5. Enantioselective Synthesis of the Alkaloids Psylloborine A and Isopsylloborine A
The complex dimers psylloborine A (63) and isopsylloborine A (64) (Figure 6) belong to coccinellid
family of alkaloids, materials secreted by numerous species of ladybugs as defensive compounds
when provoked. In the synthesis, N-Boc 9 was identified as a common starting point for the two
tricyclic intermediate of the dimerization reaction [50]; moreover, the synthetic strategy allowed the
total syntheses of eight monomeric members of these class of alkaloids.
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4.6. Enantioselective Synthesis of the Alkaloids Tetraponerines T3, T4, T7, and T8
Tetraponerines are a family of alkaloids that P eudomyrmecine ants of the genus T traponera
segregate against their enemies; their structures possess a singular aminal moiety inside a fused
tricycle. They act as paralyzing venoms since are efficient inhibitors of a range of nAChRs (nicotinic
acetylcholine receptors). Recently, enantioselective synthesis of the tetraponerines T3 (65), T4 (66),
T7 (67), and T8 (68) (Figure 7) was achieved starting from N-Cbz 2 [51,52]. Their anticancer activity,
against four different carcinoma human cell lines was examined showing a promising cytotoxic activity
of 67 against breast carcinoma cell line MCF-7.
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4.7. Enantioselective Synthesis of the Alkaloids (+)-Conhydrine and
4-(2-(Piperidin-2-yl)ethoxy)quinoline Derivatives
Other alkaloids that contain th piperidine unit are: (+)-c nhydrine (69) (Fig re 8) [53], which was
isolated in 1856 from t e seeds and leaves of the poisonous plant Conium maculatum L. an is effectively
in the treatment of cognitive disorders since it has been shown to display memory-enhancing properties;
and 4-(2-(piperidin-2-yl)ethoxy)quinoline derivatives (70), as selective agonists of somatostatin receptor
subtype 2 (Figure 8) [54].
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5. Conclusions
The discovery of both synthetic and enzymatic methods for the obtaining of enantiopure 1 opens
the way for the use of this compound as a vital starting material for the enantioselective synthesis of
natural and synthetic compounds. This review highlights the synthesis of natural alkaloids starting
from both enantiopure 2-piperidineethanol and its corresponding derivative N-protected aldehyde 2.
Author Contributions: All authors contributed to the development of the overall structure and the writing of
the manuscript.
Conflicts of Interest: The authors declare no conflict of interest.
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